Design, synthesis, and pharmacological Evaluation of 2‑(2,5-Dimethyl-5,6,7,8-tetrahydroquinolin-8-yl)‑N‑aryl Propanamides as Novel Smoothened (Smo) Antagonists
Liu, G.; Xue, D.; Yang, J.; Wang, J.; Liu, X.; Huang, W.; Li, J.; Long, Y.-Q.*; Tan, W.;* and Zhang, A.*
J. Med. Chem.2016, 59, 11050-11068.
GPR40 agonists for the treatment of type 2 diabetes mellitus: the biological characteristics and the chemical space.
Chen, C.; Li, H.; Long, Y.-Q.*
Bioorg. Med. Chem. Lett.2016, 26(23), 5603-5612.
Structure-based optimization and derivatization of 2-substituted quinolone-based non-nucleoside HCV NS5B inhibitors with submicromolar cellular replicon potency.
Cheng, Y.; Shen, J.; Peng, R.-Z.; Wang, G.-F.; Zuo, J.-P.*; Long, Y.-Q.*
Bioorg. Med. Chem. Lett.2016, 26, 2900-2906.